Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sarcoma 10Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 4Leukemia 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Hodgkin Disease 3Central Nervous System Neoplasms 3Testicular Germ Cell Tumor 2Relapsed Pediatric Solid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, T-Cell, Peripheral 2Fallopian Tube Neoplasms 2Burkitt Lymphoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Unresectable Sinonasal Tumors 1Teratoma 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Sinonasal Tumors 1Seminoma 1

Interventions

prednylidene 1pirarubicin 1etoposide phosphate 1Vincristine 1Prednisone 1Methotrexate 1Ifosfamide 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Subcutaneous panniculitis-like T-cell lymphoma × Ifosfamide × Clear all
NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡